| ADSCs | Adipose-derived stem cells |
| AGEs | Advanced glycation end products |
| Aire | Autoimmune regulator |
| Akt | Protein kinase B |
| AMPK | AMP-activated protein kinase |
| APCs | Antigen-presenting cells |
| APOB | Apolipoprotein B |
| ATP | Adenosine triphosphate |
| AUC | Area under the curve |
| Bregs | Regulatory B cells |
| CCL2 | C-C motif chemokine ligand 2 |
| CCR7 | C-C chemokine receptor 7 |
| CD | Cluster of differentiation |
| cDC1s | Conventional type 1 dendritic cells |
| cDC2s | Conventional type 2 dendritic cells |
| CXCL10 | C-X-C motif chemokine ligand 10 |
| DAMPs | Damage-associated molecular patterns |
| DCs | Dendritic cells |
| DKD | Diabetic kidney disease |
| eGFR | Estimated glomerular filtration rate |
| eNOS | Endothelial nitric oxide synthase |
| GAD65 | Glutamic acid decarboxylase 65 |
| GM-CSF | Granulocyte-macrophage colony-stimulating factor |
| HbA1c | Glycated hemoglobin |
| HIF-1α | Hypoxia-inducible factor-1α |
| HMGB1 | High-mobility group box 1 |
| HO-1 | Heme oxygenase-1 |
| HSP70 | Heat shock protein 70 |
| Hsp60 | Heat shock protein 60 |
| Hsp60sp | Heat shock protein 60 signal peptide |
| IA-2 | Insulinoma-associated antigen-2 |
| IDO-1 | Indoleamine 2,3-dioxygenase-1 |
| IFN-I | Type I interferon |
| IFNAR | Interferon-α/β receptor |
| IFN-γ | Interferon-γ |
| IL | Interleukin |
| ILT3 | Immunoglobulin-like transcript 3 |
| iNKT cells | Invariant natural killer T cells |
| IRFs | Interferon regulatory factors |
| JAK–STAT | Janus kinase–signal transducer and activator of transcription |
| LAEPAL | Aqueous extract of Passiflora alata leaves |
| LCs | Langerhans cells |
| LepRb | Leptin receptor b |
| LOX-1 | Lectin-like oxidized low-density lipoprotein receptor-1 |
| MAPK | Mitogen-activated protein kinase |
| mDCs | Myeloid dendritic cells |
| MHC | Major histocompatibility complex |
| miR | MicroRNA |
| moDCs | Monocyte-derived dendritic cells |
| mTOR | Mammalian target of rapamycin |
| MyD88 | Myeloid differentiation primary response 88 |
| NAD+ | Nicotinamide adenine dinucleotide |
| NETs | Neutrophil extracellular traps |
| NF-κB | Nuclear factor-κB |
| NK cells | Natural killer cells |
| NKT cells | Natural killer T cells |
| NLRP3 | NLR family pyrin domain-containing protein 3 |
| NOD | Non-obese diabetic |
| NR | Not reported |
| oxLDL | Oxidized low-density lipoprotein |
| P2X7 | P2X purinoceptor 7 |
| PAMPs | Pathogen-associated molecular patterns |
| PBMCs | Peripheral blood mononuclear cells |
| PD-1 | Programmed cell death protein 1 |
| PD-L1 | Programmed cell death ligand 1 |
| PI3K | Phosphoinositide 3-kinase |
| PKCβ1 | Protein kinase C β1 |
| PLGA | Poly(lactic-co-glycolic acid) |
| PPAR-γ | Peroxisome proliferator-activated receptor-γ |
| pDCs | Plasmacytoid dendritic cells |
| RAGE | Receptor for advanced glycation end products |
| ROS | Reactive oxygen species |
| SAEs | Serious adverse events |
| STAT3 | Signal transducer and activator of transcription 3 |
| STZ | Streptozotocin |
| T1DM | Type 1 diabetes mellitus |
| T2DM | Type 2 diabetes mellitus |
| TCR | T-cell receptor |
| TCNS | Toronto Clinical Neuropathy Score |
| TGF-β | Transforming growth factor-β |
| Th1 | T helper 1 |
| Th17 | T helper 17 |
| TLR | Toll-like receptor |
| TNF-α | Tumor necrosis factor-α |
| tolDCs | Tolerogenic dendritic cells |
| Tregs | Regulatory T cells |
| Tr1 | Type 1 regulatory T cells |
| TRIF | Toll/interleukin-1 receptor domain-containing adaptor-inducing interferon-β |
| TXNIP | Thioredoxin-interacting protein |
| UACR | Urinary albumin-to-creatinine ratio |
| VCAM-1 | Vascular cell adhesion molecule-1 |